Gabelli Funds’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Gabelli Funds’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75,500	Closed	-$2.11M	–	1174
2019 Q3	$2.11M	Buy	+75,500	New	+$1.22M	0.01%	720

Gabelli Funds's DOVA Position: Q4 2019 in Review

Gabelli Funds sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 75,500 shares — an estimated $2.11M sold.

Gabelli Funds first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $2.11M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Gabelli Funds reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Gabelli Funds sold 75,500 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.11M.
Gabelli Funds first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Gabelli Funds's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.11M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.